RT @SABOURETCardio
#PCSK9i This #MA confirms that #PCSK9i work in #T2D patients "the higher is the baseline risk, the higher are the benefits" (as usual) #lipids https://academic.oup.com/ehjcvp/advance-article-abstract/doi/10.1093/ehjcvp/pvad019/7087275?redirectedFrom=fulltext